A clear picture of what Human Performance success looks like is now available from
BioPhorum, where members of the Human Performance workstream have defined a blue …

Today, in 2014, more than 50% of deviations in the biopharmaceutical industry are the result
of human error. The highly regulated, advanced scientific and high-technology …

The recent surge in publicity about medical errors lays down the gauntlet in front of all health
professionals and has particular implications for pharmacists practicing in hospitals and …

Human performance and human error in medicine have emerged as critical health care
issues affecting the entire practice of medical treatment and health care delivery. Human …

Companies of all sizes are vying to in-crease their market share and profitability in a world of
shrinking margins, patent expirations, and R&D pipelines that are dwindling. Factors such as …

Achieving operational excellence is a growing goal among biopharmaceutical enterprises.
Companies are investing heavily in software, data marts, and data integration to achieve …

Abstract Purpose Scholars often associate Operational Excellence (OPEX) enablers with
high operational performance. Several studies have concluded that advancing OPEX …

Despite gaps in the overall translation of established Lean and Six Sigma frameworks to this
industry, potential applications of operational excellence to biopharmaceutical processing …

Human errors are an expected result of operations performed by individuals and frequently
lead to accidents and other catastrophic events. The problem is that the current process …